porcine cerebroside + porcine ganglioside

Porcine cerebroside + porcine ganglioside is a neurotrophic combination therapy derived from porcine brain tissue, primarily used in China for the treatment of central nervous system disorders such as ischemic stroke and cerebral infarction. The drug consists of gangliosides, which are essential for neuronal membrane stability and signal transduction, and cerebrosides, which are critical components of the myelin sheath. Together, these components work synergistically to provide neuroprotection, reduce excitotoxicity, and promote the repair and regeneration of damaged neural tissue. It is typically administered via intravenous injection and has been studied in Phase 4 clinical trials by institutions like the Affiliated Hospital of Zunyi Medical University to confirm its efficacy in improving neurological outcomes following acute brain injury.

Brand names

BaitaiShenyuan

Other names

Cerebroside and Ganglioside Injection猪脑苷肌肽